Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar.

about

Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar.

Item

http://www.wikidata.org/entity/Q41026410

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Arterial access site and outco ...... on with and without vorapaxar.

@en

type

Item

label

Arterial access site and outco ...... on with and without vorapaxar.

@en

prefLabel

Arterial access site and outco ...... on with and without vorapaxar.

@en

P1476

Arterial access site and outco ...... on with and without vorapaxar.

@en

P2093

Edmond Chen

http://www.w3.org/2001/XMLSchema#string

Frans Van de Werf

http://www.w3.org/2001/XMLSchema#string

Harvey D White

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Déry

http://www.w3.org/2001/XMLSchema#string

John Strony

http://www.w3.org/2001/XMLSchema#string

Khaled M Ziada

http://www.w3.org/2001/XMLSchema#string

Mohua Podder

http://www.w3.org/2001/XMLSchema#string

Philip E Aylward

http://www.w3.org/2001/XMLSchema#string

Sunil V Rao

http://www.w3.org/2001/XMLSchema#string

P2860

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012).

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.

Rivaroxaban in patients with a recent acute coronary syndrome.

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.

Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry

Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials.

Comparison of transradial and femoral approaches for percutaneous coronary interventions: a systematic review and hierarchical Bayesian meta-analysis.

Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg).

P304

163-173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CCD.26335

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cynthia M. Westerhout

P577

2015-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26698636

http://www.w3.org/2001/XMLSchema#string